Background: Mesenchymal stem cells (MSCs) are among the most frequently used cell type for regenerative medicine and have beneficial effects to treat different pathologies, including neurological disorders, cardiac ischemia, diabetes, and bone and cartilage diseases, Fortunately, MSCs, known for their lower immunogenicity and self-renewal ability, can be induced into insulin-producing cells (IPCs) and have attracted significant attention for the treatment of DM. Importantly.
No takes yet. Share an insight, caveat, or question.
Fahmy et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: